person · Reporting owner
Filho Jose Octavio Pinto Costa
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Monopar TherapeuticsMNPR · Entity 5152 | Chief Medical Officer | July 12, 2021 | July 13, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Monopar Therapeutics
Report date July 12, 2021 · Filed July 13, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $5.59 · Expires 2031-07-11 | Direct | 91,500 |
Reported balance
After 2021-07-12 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-07-12 · Grant · Acquired 91,500 · Balance 91,500 F1: Options vest 6/48ths on January 12, 2022 and 1/48th per month thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Options vest 6/48ths on January 12, 2022 and 1/48th per month thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 12, 2021 Filed Jul 13, 2021 16:35 UTC | Monopar Therapeutics MNPR · Entity 5152 | GrantStock Options · Derivative | 91,500 | $0.00 Strike: $5.59 | $0.00 |
DisclosureSEC source: 0001654954-21-007859 · section16.xml · derivative · entry 1 Filho Jose Octavio Pinto Costa · CIK 0001863625 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,500 Underlying: Common Stock · 91,500 shares Expires 2031-07-11 F1 · derivative.exercise_date: Options vest 6/48ths on January 12, 2022 and 1/48th per month thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.